Discovery of Oligosaccharide Antigens for Semi‐Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14**

Abstract Streptococcus suis bacteria are one of the most serious health problems for pigs and an emerging zoonotic agent in humans working in the swine industry. S. suis bacteria express capsular polysaccharides (CPS) a major bacterial virulence factor that define the serotypes. Oligosaccharides resembling the CPS of S. suis serotypes 2, 3, 9, and 14 have been synthesized, glycans related to serotypes 2 and 9 were placed on glycan array surfaces to screen blood from infected pigs. Lead antigens for the development of semi‐synthetic S. suis serotypes 2 and 9 glycoconjugate veterinary vaccines were identified in this way.

[1]  M. Gottschalk,et al.  Characterization and Protective Activity of Monoclonal Antibodies Directed against Streptococcus suis Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate , 2019, Pathogens.

[2]  T. Sekizaki,et al.  Characterization of pig saliva as the major natural habitat of Streptococcus suis by analyzing oral, fecal, vaginal, and environmental microbiota , 2019, PloS one.

[3]  K. VanderWaal,et al.  Global trends in infectious diseases of swine , 2018, Proceedings of the National Academy of Sciences.

[4]  E. Vinogradov,et al.  Streptococcus suis serotype 3 and serotype 18 capsular polysaccharides contain di-N-acetyl-bacillosamine. , 2018, Carbohydrate research.

[5]  K. Hoelzer,et al.  Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs , 2018, Veterinary Research.

[6]  Marla Shapiro,et al.  Understanding modern-day vaccines: what you need to know , 2018, Annals of medicine.

[7]  D. Grenier,et al.  Understanding the virulence of Streptococcus suis: A veterinary, medical, and economic challenge. , 2017, Medecine et maladies infectieuses.

[8]  N. Khan,et al.  A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. , 2017, Journal of the American Chemical Society.

[9]  N. Khan,et al.  Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5 , 2017, Proceedings of the National Academy of Sciences.

[10]  M. Gottschalk,et al.  Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response , 2017, Pathogens.

[11]  Clay S. Bennett,et al.  Mild Method for 2-Naphthylmethyl Ether Protecting Group Removal Using a Combination of 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and β-Pinene , 2017, The Journal of organic chemistry.

[12]  Xuefei Huang,et al.  Obstacles and solutions for chemical synthesis of syndecan-3 (53-62) glycopeptides with two heparan sulfate chains. , 2016, Carbohydrate research.

[13]  M. Gottschalk,et al.  Structure determination of Streptococcus suis serotype 9 capsular polysaccharide and assignment of functions of the cps locus genes involved in its biosynthesis. , 2016, Carbohydrate research.

[14]  Yueqi Zhao,et al.  Remote Activation of Disarmed Thioglycosides in Latent-Active Glycosylation via Interrupted Pummerer Reaction. , 2016, Journal of the American Chemical Society.

[15]  Peter H Seeberger,et al.  Automated assembly of oligosaccharides containing multiple cis-glycosidic linkages , 2016, Nature Communications.

[16]  Mads Heuckendorff,et al.  Remote Electronic Effects by Ether Protecting Groups Fine-Tune Glycosyl Donor Reactivity. , 2016, The Journal of organic chemistry.

[17]  M. Segura.  Streptococcus suis vaccines: candidate antigens and progress , 2015, Expert review of vaccines.

[18]  Jianguo Xu,et al.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent—an update on the worldwide distribution based on serotyping and sequence typing , 2014, Emerging Microbes & Infections.

[19]  M. Oberli,et al.  Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. , 2013, Chemical communications.

[20]  A. Potter,et al.  Carrier molecules for use in veterinary vaccines. , 2013, Vaccine.

[21]  N. Fittipaldi,et al.  Sialylation of Streptococcus suis serotype 2 is essential for capsule expression but is not responsible for the main capsular epitope. , 2012, Microbes and infection.

[22]  N. Fittipaldi,et al.  Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. , 2012, Future microbiology.

[23]  J. P. Yasomanee,et al.  Glycosidation of thioglycosides in the presence of bromine: mechanism, reactivity, and stereoselectivity. , 2012, The Journal of organic chemistry.

[24]  Van CalsterenMarie-Rose,et al.  Structure determination of Streptococcus suis serotype 14 capsular polysaccharide , 2010 .

[25]  Dennis R. Burton,et al.  Carbohydrate vaccines: developing sweet solutions to sticky situations? , 2010, Nature Reviews Drug Discovery.

[26]  P. Sawanpanyalert,et al.  Clonal dissemination of human isolates of Streptococcus suis serotype 14 in Thailand. , 2009, Journal of medical microbiology.

[27]  P. Seeberger,et al.  Chemical synthesis of all phosphatidylinositol mannoside (PIM) glycans from Mycobacterium tuberculosis. , 2008, Journal of the American Chemical Society.

[28]  D. Kahne,et al.  The total synthesis of moenomycin A. , 2006, Journal of the American Chemical Society.

[29]  M. Parrilli,et al.  A Versatile Strategy for the Synthesis of N-Acetyl-bacillosamine-Containing Disaccharide Building Blocks Related to Bacterial O-Antigens , 2006 .

[30]  Biao Yu,et al.  Efficient sialylation with phenyltrifluoroacetimidates as leaving groups. , 2003, Organic letters.

[31]  V. Dudkin,et al.  Why are the hydroxy groups of partially protected N-acetylglucosamine derivatives such poor glycosyl acceptors, and what can be done about it? A comparative study of the reactivity of N-acetyl-, N-phthalimido-, and 2-azido-2-deoxy-glucosamine derivatives in glycosylation. 2-Picolinyl ethers as react , 2001, Journal of the American Chemical Society.

[32]  M. Jacques,et al.  Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. , 1997, Microbiology.

[33]  Takeshi Yamamoto,et al.  A Novel α-2,6-Sialyltransferase: Transfer of Sialic Acid to Fucosyl and Sialyl Trisaccharides , 1996 .

[34]  J. Saunders,et al.  Discovery of a novel protein modification: alpha-glycerophosphate is a substituent of meningococcal pilin. , 1996, The Biochemical journal.

[35]  R. Little,et al.  Intramolecular 1,3-diyl trapping reactions. A formal total synthesis of (.+-.)-coriolin , 1985 .

[36]  E. Vinogradov,et al.  Structure determination of Streptococcus suis serotypes 7 and 8 capsular polysaccharides and assignment of functions of the cps locus genes involved in their biosynthesis. , 2019, Carbohydrate research.

[37]  P. Seeberger,et al.  Synthetic Glycan Microarrays. , 2017, Methods in molecular biology.

[38]  I. Roberts.  The biochemistry and genetics of capsular polysaccharide production in bacteria. , 1996, Annual review of microbiology.

[39]  B. Imperiali,et al.  Biochemical Characterization of the O-linked Glycosylation Pathway in Neisseria Gonorrhoeae Responsible for Biosynthesis of Protein Glycans Accessed Terms of Use Detailed Terms Biochemical Characterization of the O-linked Glycosylation Pathway in Neisseria Gonorrhoeae Responsible for Biosynthesis of , 2022 .